Search for: "Anda Pharmaceuticals, Inc"
Results 81 - 100
of 604
Sorted by Relevance
|
Sort by Date
16 Mar 2009, 8:52 pm
By Suresh Pillai -- Sepracor Settles Xopenex Suit With Barr Last week, Sepracor Inc. and Barr Pharmaceuticals, Inc. [read post]
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
18 Oct 2009, 5:42 pm
Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE ® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
19 Mar 2010, 8:49 am
Plaintiffs filed this patent infringement action against defendants Anchen Pharmaceuticals and Anchen Inc. after the defendants filed their Abbreviated New Drug Application (“ANDA”) to manufacture generic versions of AMRIX®. [read post]
12 Aug 2010, 9:18 pm
By James DeGiulio -- Cephalon and Mylan Pharmaceuticals Agree to Drop Two Patents from Nuvigil Patent Suit Cephalon Inc. and Mylan Pharmaceuticals Inc. have agreed to drop two of the three patents originally involved in their infringement suit over the narcolepsy drug Nuvigil. [read post]
1 Jun 2014, 9:25 am
• Defendants: Breckenridge Pharmaceutical Inc.; Natco Pharma Ltd. [read post]
9 Jan 2013, 11:01 pm
Watson Pharmaceuticals, Inc., to address whether and when “reverse payment” agreements made to settle ANDA litigation violate antitrust laws. [read post]
14 Sep 2014, 9:59 pm
Millennium Pharmaceuticals Inc. v. [read post]
26 Dec 2010, 9:59 pm
Sandoz, Inc., the Federal Circuit vacated the entry of a consent judgment and an injunction by the District Court for the District of New Jersey, which enjoined Defendants-Appellants Sun Pharmaceutical Industries, Ltd. and Caraco Pharmaceutical Laboratories, Ltd. [read post]
9 May 2014, 8:14 am
Avanir Pharmaceuticals, Inc., et al. v. [read post]
17 Nov 2014, 9:59 pm
• Defendants: Pharmadax USA, Inc.; Pharmadax Inc.; Pharmadax (Guangzhou) Inc. [read post]
15 Dec 2020, 12:21 pm
Mylan Pharmaceuticals, Inc. [read post]
23 Jun 2013, 8:50 pm
• Defendants: Par Pharmaceutical Inc.; Actavis Elizabeth LLC; Actavis Inc. [read post]
26 Oct 2014, 9:17 pm
• Defendants: Pharmadax USA, Inc.; Pharmadax Inc.; Pharmadax Guangzhou Inc. [read post]
20 Aug 2010, 8:11 am
Fresenius Medical Care Holdings, Inc. v. [read post]
5 Sep 2007, 8:38 pm
Noonan -- The Federal Circuit today affirmed a District Court finding that ANDA filer Ivax Pharmaceuticals and co-Defendant Cipla had not shown by clear and convincing evidence that Forest Laboratories' patent-in-suit for Lexapro ® was invalid. [read post]
20 May 2010, 9:59 pm
Inc., now URL Pharma. [read post]
24 Oct 2008, 11:37 am
Swiss-drug major Novartis has filed a lawsuit in the US District Court for the District of New Jersey against Mylan Pharmaceuticals Inc. for infringement of Orange Book listed US Patent No. 5,354,772 (the ‘772 patent) for Lescol capsules, generically known as Fluvastatin Sodium. [read post]
1 Mar 2015, 9:59 pm
Par Pharmaceutical, Inc. et al. 1:15-cv-01454; filed February 25, 2015 in the District Court of Massachusetts • Plaintiff: Shire LLC • Defendants: Par Pharmaceutical, Inc.; Par Pharmaceutical Companies, Inc. [read post]
29 Jun 2014, 9:21 pm
Mylan Inc. et al. 1:14-cv-00777; filed June 19, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; LTS Lohmann Therapie-Systeme AG • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
